Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02891031Unknown
Randomised, double-blind trial in hyperuricemia comparing Rhus (Somagh) with Placebo (2 arms). Primary endpoint: Serum uric acid at 6 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02891031.